Literature DB >> 19262540

Proton pump inhibitor use and enteric infections.

M Sandra Dial1.   

Abstract

Proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) are very commonly prescribed drugs and are routinely used in the chronic management of gastro-esophageal reflux disease. Concerns have been raised about the possible association of PPIs with enteric infections. This article reviews the studies that have examined the associations of proton pump inhibitors in particular, and enteric infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262540     DOI: 10.1038/ajg.2009.46

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

Review 1.  The risks of PPI therapy.

Authors:  Paul Moayyedi; Grigorios I Leontiadis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

2.  Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.

Authors:  Patrick S Yachimski; Elizabeth A Farrell; Daniel P Hunt; Andrea E Reid
Journal:  Arch Intern Med       Date:  2010-05-10

Review 3.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

4.  Gastroesophageal reflux disease: Important considerations for the older patients.

Authors:  Maxwell M Chait
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

Review 5.  The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.

Authors:  Artem Minalyan; Lilit Gabrielyan; David Scott; Jonathan Jacobs; Joseph R Pisegna
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 6.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

7.  A case of a chronic salmonella infection following Roux-en-Y gastric bypass surgery, treated successfully by a laparoscopic cholecystectomy.

Authors:  Zohaib Siddiqui; Zain Ahmed Siddiqui; Fahd Husain; Midhat Siddiqui
Journal:  BMJ Case Rep       Date:  2017-06-08

8.  Use of Gastroesophageal Reflux Medications in Premature Infants After NICU Discharge.

Authors:  Jo Ann D'Agostino; Molly Passarella; Ashley E Martin; Scott A Lorch
Journal:  Pediatrics       Date:  2016-12       Impact factor: 7.124

9.  Inhibition of lysosomal enzyme activities by proton pump inhibitors.

Authors:  Wensheng Liu; Susan S Baker; Jonathan Trinidad; Alma L Burlingame; Robert D Baker; John G Forte; Lauren P Virtuoso; Nejat K Egilmez; Lixin Zhu
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

Review 10.  How May Proton Pump Inhibitors Impair Cardiovascular Health?

Authors:  Roman A Sukhovershin; John P Cooke
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.